Patient Treatment & Support

Seattle Cancer Care Alliance, which shares our campus, provides care to patients being treated by physicians from Fred Hutch, Seattle Children's  and UW Medicine. As our clinical care partner, SCCA offers state-of-the-art, multidisciplinary cancer care, including diagnostic, surgical and medical services, chemotherapy and radiation therapy and an array of supportive and follow-up care services. SCCA also has one of the most active clinical trial programs in the world, providing patients with access to promising new treatment strategies developed at Fred Hutch.

Clinical research nurse Colette Chaney checks the details of a patient's records at the University of Washington Clinical Research Center

Find a Clinical Trial

Through our clinical trials, patients gain access to promising new treatments for cancer and other diseases. Our observational studies, which are also crucial to determining cause and effect in human health, often seek healthy participants for prevention research.

Allen Everson get an exam at the SCCA outpatient clinic

Patients and their physicians can request appointments at SCCA, including its specialty clinics such as the Bone Marrow Transplant Program, Proton Therapy Center and the Prostate Cancer Genetics Clinic.

Heather Cheng talks with a patient

Meet Our Clinicians

About 100 leading Fred Hutch experts provide clinical care to patients through SCCA for a number of types of cancer and other diseases.

Preparing for Your First Visit

SCCA offers an online Patient Guide to help people prepare for their first visit and learn about SCCA services and resources. Fred Hutch and SCCA offer reasonably priced accommodations and amenities for patients and their families while the patients are receiving care in Seattle. Other helpful information is available on the Classes and Events page.  
 

Understanding Your Diagnosis

See a collection of informative articles and stories that address many of the concerns and questions that patients and survivors have. Topics include diagnosis, treatment and life after cancer.

Survivorship Program

Our Survivorship Program offers patients support, consultation, treatment and education after their cancer treatment ends. It enables survivors to take an active role in maintaining their health and works with them to develop individualized care plans.

LEARN MORE ABOUT SURVIVORSHIP

Long-Term Follow-Up Program

Our Long-Term Follow-Up program provides lifelong monitoring and care to patients who have had a bone marrow or blood stem cell transplant through our transplant program. Physicians and researchers work with each patient’s primary care doctor to resolve medical problems and educate the patient about preventing and managing post-transplant issues.

Learn about LTFU Services

Cancer Information and Resources

Prospective patients, their families and their caregivers need information on cancer, treatment options, access to care and supportive services. The resources listed below are a good place to start, along with the SCCA and Fred Hutch websites.

Survivorship and Support

+

Fred Hutch Survivorship Program
American Childhood Cancer Organization
Association of Cancer Online Resources
Cancer Care
Cancer Hope Network
Cancer Lifeline (Seattle area)
Cancer Pathways (formerly Gilda's Club Seattle)
Cancer Support Community
CancerVive
Caregiver Action Network
Caring Bridge (personal health journals for patients and families)
Cierra Sisters (African-American cancer support group)
Colontown (online communities)
Daily Strength (online communities)
ECANA (Endometrial Cancer Action Network for African-Americans)
FORCE (Facing Our Risk of Cancer Empowered)
Inspire (online communities)
LIVESTRONG Foundation
MedHelp (online communities)
Metavivor
National Cancer Institute’s Office of Cancer Survivorship
PAN Foundation (financial help for patients)
Patients Like Me (online communities)
SmartPatients (online communities)
Team Survivor Northwest

Pediatric Resources

+

A Patient’s Story

Pam Mellick

Pam Mellick

Pam Mellick was diagnosed with an aggressive form of breast cancer in her late 50s. She wanted choices, and she ultimately opted to participate in a clinical trial at SCCA.

Last Modified, October 02, 2019